Analysts Conflicted on These Healthcare Names: Cartesian Therapeutics (RNAC), Insmed (INSM) and BioNTech SE (BNTX)
TipRanksApr 23 06:40 ET
Insmed Analyst Ratings
BenzingaApr 23 06:39 ET
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and UnitedHealth (UNH)
TipRanksApr 16 13:20 ET
Insmed Analyst Ratings
BenzingaApr 11 09:26 ET
Insmed Analyst Ratings
BenzingaApr 1 11:59 ET
Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)
TipRanksApr 1 06:03 ET
Strong Endorsement and Market Expansion Potential Justify Buy Rating for Insmed's Brensocatib
TipRanksMar 19 02:08 ET
Analysts Conflicted on These Healthcare Names: Insmed (INSM), Oric Pharmaceuticals (ORIC) and CytomX Therapeutics (CTMX)
TipRanksMar 12 08:20 ET
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Zimmer Biomet Holdings (ZBH)
TipRanksMar 7 07:30 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Insmed (INSM)
TipRanksMar 5 07:40 ET
Buy Rating Affirmed for Insmed on Positive Pipeline Prospects and Robust Revenue Forecasts
TipRanksFeb 28 00:06 ET
Insmed Analyst Ratings
BenzingaFeb 27 12:10 ET
Insmed Analyst Ratings
BenzingaFeb 27 05:37 ET
Buy Rating Affirmed for Insmed on Strong Sales and Promising Trial Outlook
TipRanksFeb 25 23:26 ET
Barclays Sticks to Its Buy Rating for Insmed (INSM)
TipRanksFeb 23 03:16 ET
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and BioMarin Pharmaceutical (BMRN)
TipRanksFeb 22 22:50 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: American Well (AMWL), Biogen (BIIB) and Insmed (INSM)
TipRanksFeb 15 06:40 ET
Insmed Analyst Ratings
BenzingaFeb 15 06:22 ET
Buy Rating Affirmed for Insmed Amid Competitor Setbacks and Promising Market Expansion Opportunities
TipRanksFeb 15 01:37 ET
AN2 Therapeutics Extends Losses as Leerink Cuts on Trial Setback
Seeking AlphaFeb 13 11:26 ET
No Data
No Data